DK1000154T3 - Identificering af humane cellelinjer til produktion af humane proteiner ved endogen genaktivering - Google Patents

Identificering af humane cellelinjer til produktion af humane proteiner ved endogen genaktivering

Info

Publication number
DK1000154T3
DK1000154T3 DK98942592T DK98942592T DK1000154T3 DK 1000154 T3 DK1000154 T3 DK 1000154T3 DK 98942592 T DK98942592 T DK 98942592T DK 98942592 T DK98942592 T DK 98942592T DK 1000154 T3 DK1000154 T3 DK 1000154T3
Authority
DK
Denmark
Prior art keywords
human
production
endogenous gene
gene activation
identification
Prior art date
Application number
DK98942592T
Other languages
English (en)
Inventor
Michael Brandt
Reinhard Franze
Ulrich Pessara
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27238256&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1000154(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US09/113,692 external-priority patent/US6548296B1/en
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Application granted granted Critical
Publication of DK1000154T3 publication Critical patent/DK1000154T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK98942592T 1997-07-23 1998-07-22 Identificering af humane cellelinjer til produktion af humane proteiner ved endogen genaktivering DK1000154T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP97112640 1997-07-23
EP97121073 1997-12-01
US09/113,692 US6548296B1 (en) 1997-07-23 1998-07-10 Methods for identifying human cell lines useful for endogenous gene activation, isolated human lines identified thereby, and uses thereof
PCT/EP1998/004584 WO1999005267A1 (de) 1997-07-23 1998-07-22 Identifizierung humaner zellinien zur produktion humaner proteine durch endogene genaktivierung

Publications (1)

Publication Number Publication Date
DK1000154T3 true DK1000154T3 (da) 2007-06-18

Family

ID=27238256

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98942592T DK1000154T3 (da) 1997-07-23 1998-07-22 Identificering af humane cellelinjer til produktion af humane proteiner ved endogen genaktivering

Country Status (14)

Country Link
US (1) US6395484B1 (da)
EP (1) EP1000154B1 (da)
JP (1) JP2001511342A (da)
CN (1) CN1150319C (da)
AT (1) ATE354654T1 (da)
AU (1) AU737605B2 (da)
BR (1) BR9811542A (da)
CA (1) CA2298412C (da)
DE (1) DE59813913D1 (da)
DK (1) DK1000154T3 (da)
ES (1) ES2281133T3 (da)
TR (1) TR200000140T2 (da)
TW (1) TWI224140B (da)
WO (1) WO1999005267A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100622203B1 (ko) * 1997-07-23 2006-09-07 로셰 디아그노스틱스 게엠베하 내인성 유전자 활성화에 의해 사람 단백질을 생성시키는 사람 세포주를 확인하는 방법
GB0200977D0 (en) * 2002-01-17 2002-03-06 Lonza Biologics Plc Glutamine-auxotrophic human cells capable of producing proteins and capable of growing in a glutamine-free medium
CN1296485C (zh) * 2002-01-17 2007-01-24 英国龙沙生物医药股份有限公司 能够产生蛋白质及能够在无谷氨酰胺的培养基上生长的谷氨酰胺营养缺陷型人类细胞
GB0208041D0 (en) * 2002-04-08 2002-05-22 Lonza Biologics Plc Method of culturing animal cells
US8409861B2 (en) 2003-08-08 2013-04-02 Sangamo Biosciences, Inc. Targeted deletion of cellular DNA sequences
US11311574B2 (en) 2003-08-08 2022-04-26 Sangamo Therapeutics, Inc. Methods and compositions for targeted cleavage and recombination
US7888121B2 (en) 2003-08-08 2011-02-15 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
WO2005083060A1 (en) 2004-03-01 2005-09-09 Kitakyushu Foundation For The Advancement Of Industry, Science And Technology Human cell strains for protein production, provided by selecting strains with high intracellular protein and mutating with carcinogens
DE102012009849A1 (de) 2012-05-21 2013-11-21 Hartwig Schwieger Schwingungsstabilisierte Windenergieanlage-Zug-Druck-Knoten
JP6652334B2 (ja) 2014-05-31 2020-02-19 Ｊｃｒファーマ株式会社 ウリジンとｎ−アセチル−ｄ−マンノサミンとを含有する培地
US12188042B2 (en) 2018-07-09 2025-01-07 NanoCav, LLC Electroporation devices and methods of cell transfection
WO2020014264A1 (en) * 2018-07-09 2020-01-16 NanoCav, LLC Micro flow-through electroporation devices and methods of cell transfection
US12527950B2 (en) 2018-07-09 2026-01-20 NanoCav, LLC Electroporation devices and methods of cell transfection

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL77081A (en) 1984-12-04 1999-10-28 Genetics Inst Dna sequence encoding human erythropoietin process for the preparation thereof and a pharmaceutical composition of human erythropoietin
JPS62171696A (ja) 1986-01-23 1987-07-28 Sumitomo Chem Co Ltd ヒトエリスロポエチンの製造方法
US4954437A (en) * 1986-09-15 1990-09-04 Integrated Genetics, Inc. Cell encoding recombinant human erythropoietin
JP2879906B2 (ja) * 1989-09-14 1999-04-05 鐘紡株式会社 プロコラゲナーゼの製造方法
SG88714A1 (en) * 1989-11-06 2002-05-21 Cell Genesys Inc Production of proteins using homologous recombination
US5328844A (en) * 1990-05-09 1994-07-12 University Of Colorado Foundation, Inc. Culture media for mammalian cells
US6270989B1 (en) * 1991-11-05 2001-08-07 Transkaryotic Therapies, Inc. Protein production and delivery
NZ245015A (en) 1991-11-05 1995-12-21 Transkaryotic Therapies Inc Delivery of human growth hormone through the administration of transfected cell lines encoding human growth hormone, which are physically protected from host immune response; the transfected cells and their production
US5641670A (en) 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
TW402639B (en) * 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
US5449015A (en) * 1994-05-12 1995-09-12 Petkovic; Tony Shock-activated shut-off valve

Also Published As

Publication number Publication date
ES2281133T3 (es) 2007-09-16
BR9811542A (pt) 2000-08-22
JP2001511342A (ja) 2001-08-14
CN1150319C (zh) 2004-05-19
WO1999005267A1 (de) 1999-02-04
TWI224140B (en) 2004-11-21
AU737605B2 (en) 2001-08-23
US6395484B1 (en) 2002-05-28
AU9067498A (en) 1999-02-16
CA2298412A1 (en) 1999-02-04
CN1265144A (zh) 2000-08-30
TR200000140T2 (tr) 2000-05-22
EP1000154B1 (de) 2007-02-21
ATE354654T1 (de) 2007-03-15
CA2298412C (en) 2010-10-19
EP1000154A1 (de) 2000-05-17
DE59813913D1 (de) 2007-04-05

Similar Documents

Publication Publication Date Title
IS4626A (is) Ferli til stýringar á síalsýrumagni próteina sem framleiddar eru í spendýrafrumurækt
DE69906977D1 (de) In liposomen verkapselte nukleinsäurekomplexe
DK1650307T3 (da) Fremgangsmåde til fremstilling af rekombinante proteiner ved anvendelse af apoptoseinhibitorer
DE3686050D1 (de) Vorrichtung zur kultivierung von zellen in vitro.
DE69840678D1 (de) Verfahren zur produktion von purinnukleosiden durch fermentation
NO984565D0 (no) Influensavirus replikert i pattedyrcellekultur og vaksinefremstilling
EP0795606A4 (en) Process for producing transformed cell
DK0506884T3 (da) Fremgangsmåde til afgivelse af molekyler til eukaryotiske celler
WO2002078524A3 (en) Translational profiling
AU9200398A (en) A process to study changes in gene expression in granulocytic cells
AU2002356749A1 (en) Process for the production of polypeptides in mammalian cell cultures
DE69617583D1 (de) In vitrozellkultur-System
ATE354654T1 (de) Identifizierung humaner zellinien zur produktion humaner proteine durch endogene genaktivierung
ATE437951T1 (de) Intrazelluläre herstellung von verkürztem hepatitis c-polypeptid e2
ATE431416T1 (de) Enzymatische synthese von deoxyribonucleotiden
EP0767841A4 (en) Taxane production in haploid-derived cell cultures
ATE259369T1 (de) Neue geranylgeranylderivate, verfahren zu deren herstellung und entsprechende pharmazeutische zusammensetzungen
DE69801860D1 (de) Verfahren zur Herstellung von Wasserstoffspeicherlegierungspulver und elektrode, die dieses Pulver enthält
EP0945073A3 (en) Process of production of natural flavor or fragrance
ATE103989T1 (de) Monoklonale antikoerper gegen e7-protein des humanen papillomvirus typ 16, verfahren zu ihrer herstellung sowie ihre verwendung.
DE69933699D1 (de) Verfahren zur produktion rekombinanter proteine in säugetierzellen durch co-expression mit fetuin
DK0977859T3 (da) Den neurotrofiske faktor NNT-1
AR016774A1 (es) Identificacion de lineas celulares humanas para la produccion de proteinas humanas por activacion genica endogena
ATE327318T1 (de) Fermentationsverfahren mit kontinuierlicher massenkultivierung von ciliaten (protozoa) zur produktion biogener wertstoffe
YU28490A (sh) Produkcija superoksid dismutaze u ćelijama kvasca pichia pastoris